Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >CXL-1020
CXL-1020
  • CXL-1020

CXL-1020 NEW

Price $1520 $1980 $2500
Package 25mg 50mg 100mg
Min. Order:
Supply Ability: 10g
Update Time: 2025-10-27

Product Details

Product Name: CXL-1020 CAS No.: 950834-06-7
Supply Ability: 10g Release date: 2025/10/27

Product Introduction

Bioactivity

NameCXL-1020
DescriptionCXL-1020, a nitroxyl (HNO) prodrug, enhances cardiac inotropy/lusitropy and Ca 2+ cycling in rats exhibiting abnormal relaxation, induces vasorelaxation, and augments cardiac function in canine models. It has been investigated for its potential in treating systolic and stable heart failure [1].
In vivoCXL-1020, administered at a dosage of 100 μg/kg/min via a 30-minute infusion, significantly improves hemodynamics and cardiac functionality, enhancing both diastolic and systolic performance in mice [1]. Conversely, at dosages of 3 and 10 mg/kg/min through a 4-hour intravenous infusion, CXL-1020 elevates left ventricular systolic and diastolic functions in dogs suffering from advanced heart failure [2]. In an animal model using adult male Sprague-Dawley rats (250-350 g; with cardiac dysfunction induced by isoproterenol) [1], the administration of CXL-1020 at 100 μg/kg/min for 30 minutes noticeably improved hemodynamics and cardiac function in normal rats, and substantially boosted both diastolic and systolic performance in cardiac dysfunction mice. Similarly, in dogs with heart failure induced by coronary microembolization [2], dosages of 3 and 10 mg/kg/min resulted in a dose-dependent improvement in cardiac function, evidenced by a modest decrease in systolic aortic pressure (AoP), a significant increase in ejection fraction (EF) and early mitral inflow velocity deceleration time (DT), and a significant reduction in left ventricular end-systolic volume (ESV), end-diastolic pressure (EDP), and end-diastolic wall stress (EDWS).
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Inhibitors RelatedNisoldipine | 2,4,6-Tri-tert-butylphenol | Diltiazem hydrochloride | Praziquantel | Cromolyn sodium | L-Ascorbic acid | L-Phenylalanine | Ethyl cinnamate | L-Ascorbic acid sodium salt | 1-Octanol | 2-Nitrobenzoic acid | Cinchonine

Company Profile Introduction

TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds. 170+ Compound Libraries, 10000+ Noval Small Molecucles,16000+ Nature Compounds TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$337.00/1mg
VIP6Y
TargetMol Chemicals Inc.
2025-04-27

TargetMol Chemicals Inc.

2YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, Massachusetts, USA
INQUIRY